Giant Biogene Holding Co., Ltd. (2367.HK) HKSE

35.64

-0.1(-0.28%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap46.92B
Enterprise Value42.9B
P/E Ratio14.85
PEG Ratio1.82
Price/Sales Ratio5.54
Price/Book Ratio3.66
Enterprise/Revenue4.4
Enterprise/EBITDA10.36

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.37
Operating Margin0.42

Management Effectiveness

Return On Assets0.2
Return On Equity0.28

Income Statement

Revenue5.54B
Revenue/Share5.84
Gross Profit4.55B
EBITDA2.31B
Net Income2.06B
Diluted EPS2.06

Balance Sheet

Total Cash8.86B
Total Cash/Share6.64
Total Debt6.95M
Total Debt/Equity0
Current Ratio4.87
Book Value Per Share8.78

Price History

52-Week Change-29.07
52-Week High87.1
52-Week Low34.04
Moving Average 50 Days37.78
Moving Average 200 Days57.2

Statistics

Average Volume11.89M
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.18
Trailing Annual Dividend Yield3.66
Payout Ratio0.4
Last Split FactorN/A
Last Split DateN/A